NEW YORK (GenomeWeb) – KromaTid today announced it has selected Tebu-bio as its European distribution partner. 

Tebu-bio will distribute Fort Collins, Colo.-based KromaTid's genome imaging assays, which can determine DNA sequence, location, and orientation in a single test. KromaTiD's assays can detect genetic rearrangements, such as chromosomal inversions and translocations, that are missed by other diagnostic tools, the firm said in a statement. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.